<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>P. Todeschini | Romualdi Lab</title>
    <link>/author/p.-todeschini/</link>
      <atom:link href="/author/p.-todeschini/index.xml" rel="self" type="application/rss+xml" />
    <description>P. Todeschini</description>
    <generator>Wowchemy (https://wowchemy.com)</generator><language>en-us</language><copyright>Â© Research Group</copyright><lastBuildDate>Fri, 01 Jan 2021 00:00:00 +0000</lastBuildDate>
    <image>
      <url>/images/icon_hud8b169d6400d4e9e77db720aa3284c6d_12325_512x512_fill_lanczos_center_2.png</url>
      <title>P. Todeschini</title>
      <link>/author/p.-todeschini/</link>
    </image>
    
    <item>
      <title>Comprehensive profiling of hypoxia-related mirnas identifies mir-23a-3p overexpression as a marker of platinum resistance and poor prognosis in high-grade serous ovarian cancer</title>
      <link>/publication/2021-01-01_comprehensive_profil/</link>
      <pubDate>Fri, 01 Jan 2021 00:00:00 +0000</pubDate>
      <guid>/publication/2021-01-01_comprehensive_profil/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Expression profiles of PRKG1, SDF2L1 and PPP1R12A are predictive and prognostic factors for therapy response and survival in high-grade serous ovarian cancer</title>
      <link>/publication/2020-01-01_expression_profiles_/</link>
      <pubDate>Wed, 01 Jan 2020 00:00:00 +0000</pubDate>
      <guid>/publication/2020-01-01_expression_profiles_/</guid>
      <description></description>
    </item>
    
    <item>
      <title>FXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients</title>
      <link>/publication/2019-01-01_fxyd5_dysadherin_u/</link>
      <pubDate>Tue, 01 Jan 2019 00:00:00 +0000</pubDate>
      <guid>/publication/2019-01-01_fxyd5_dysadherin_u/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts</title>
      <link>/publication/2017-01-01_circulating_mirna_la/</link>
      <pubDate>Sun, 01 Jan 2017 00:00:00 +0000</pubDate>
      <guid>/publication/2017-01-01_circulating_mirna_la/</guid>
      <description></description>
    </item>
    
  </channel>
</rss>
